Our methylation and expression analyses of RASSF1A support the hypothesis that infrequent hypermethylation of the RASSF1A promoter in normal cells precedes the formation of tumor cells, thus explaining the more frequently detected hypermethylation found in most CC-RCCs. The gene discussed is RASSF1; the disease is neoplasm.